The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 12, 2016
Filed:
May. 19, 2015
Applicant:
Pfizer Inc., New York, NY (US);
Inventors:
Joseph Francis Krzyzaniak, Pawcatuck, CT (US);
Jason Albert Leonard, New Rochelle, NY (US);
Assignee:
Pfizer Inc., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 207/34 (2006.01); C07D 295/037 (2006.01); C07C 211/07 (2006.01); C07C 215/08 (2006.01); C07C 229/26 (2006.01); C07D 295/027 (2006.01);
U.S. Cl.
CPC ...
C07D 207/34 (2013.01); C07C 211/07 (2013.01); C07C 215/08 (2013.01); C07C 229/26 (2013.01); C07D 295/027 (2013.01); C07D 295/037 (2013.01);
Abstract
Novel salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid characterized by their X-ray powder diffraction pattern and solid-state NMR spectra are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia, and Alzheimer's Disease.